Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19
Front Pharmacol
.
2021 Jun 24:12:603997.
doi: 10.3389/fphar.2021.603997.
eCollection 2021.
Authors
Charu Sharma
1
,
Niraj Kumar Jha
2
,
M F Nagoor Meeran
3
,
Chandragouda R Patil
4
,
Sameer N Goyal
5
,
Shreesh Ojha
3
Affiliations
1
Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
2
Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, India.
3
Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
4
Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University, New Delhi, India.
5
Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule, India.
PMID:
34248612
PMCID:
PMC8265778
DOI:
10.3389/fphar.2021.603997
No abstract available
Keywords:
COVID-19; drug repurposing; immunomodulators; infection; inflammation; serratiopeptidase.